Sign up for our eNewsletters
Get the latest news and updates

Industry News

Vetter/Saarland State Chancellery/Jennifer Weyland
Minister-President of Saarland Anke Rehlinger and Senator h.c. Udo J. Vetter, Chairman of the Advisory Board and member of the owner family, shake hands at signing
Construction of the Saarland facility is scheduled to begin in 2026, with operations expected to start in 2031.
Jan. 30, 2026
WuXi Biologics
WuXi Biologic and Sinorda Biomedicine signing ceremeony of MOU
The collaboration covers preclinical pharmacology studies and clinical supply to support planned IND filings in China and the United States.
Jan. 30, 2026
Shutterstock/Canva
pharma investments, petri dish with dollar sign inside it
The financing will support global deployment of the company’s integrated, GMP-ready manufacturing facilities in Europe, Japan, and the U.S.
Jan. 29, 2026
Halo Pharma
Halo manufacturing site in Whippany, New Jersey
The move follows the sale of Noramco’s API assets and positions Halo for expanded sterile manufacturing capacity, according to the company.
Jan. 29, 2026

Learning Resources

dreamstime_xxl_249582173
dreamstime_xxl_249582173
Sponsored
Innovators are redefining bioreactor technology, cell and gene therapy manufacturing, pharmaceutical packaging, and small molecule APIs. Pharma Manufacturing’s 2025 Innovation...
Dec. 8, 2025
cover_gettyimages1320311776
cover_gettyimages1320311776
Sponsored
Faced with increasing quality, risk, and talent pressures, pharma manufacturers are embracing smart manufacturing and automation to overcome these challenges. Find out in this...
Nov. 20, 2025
dreamstime_m_45052120
dreamstime_m_45052120
Sponsored
Advancements in cleanroom technology are redefining pharmaceutical manufacturing with energy-efficient HVAC, sustainable materials, and intelligent airflow. However, much more...
Oct. 28, 2025
animal_health_brochure
Sponsored
Explore proven alternatives to fetal bovine serum (FBS). Discover how donor bovine serum and other options can reduce cost and supply risks while maintaining performance in bioproductio...
Oct. 21, 2025

Podcast

Editors' (re)View

editreview
The annual J.P. Morgan Healthcare Conference in San Francisco brought together executives who are positive about this year’s prospects for the sector.
Jan. 16, 2026
editreview
Large pharmaceutical companies have promised to invest more than $370 billion over the next five years in the U.S., driven by Trump’s threat of pharma-specific tariffs.
Dec. 19, 2025
editreview
The deal is a win for Britain’s beleaguered pharma sector and comes after President Trump threatened to impose 100% tariffs on branded drugs imported to the U.S.
Dec. 5, 2025
editreview
This week, the industry saw a flurry of pharma manufacturing investment announcements as companies continue to onshore production in the United States.
Nov. 21, 2025

Production

raleigh_skyline
Raleigh-Cary and Durham-Chapel Hill secured the first and third spots, respectively, as the nation’s most competitive markets for the production of therapeutic biologics.
Nov. 10, 2025
symphonxfinal
SymphonX, which runs all downstream unit operations in both fed-batch and continuous processes, will serve customers at Fujifilm’s Billingham manufacturing facility.
Nov. 6, 2025
elevatebiofinal
With $1.3 billion in funding, the company has established a cGMP manufacturing facility in Waltham, Massachusetts, with a second site under construction in Pittsburgh.
Nov. 5, 2025
motm_cgt_manufacturingfinal
Panelists at the 2025 Cell & Gene Meeting on the Mesa laid out the challenges and opportunities facing the industry as it looks to produce these therapies at scale.
Oct. 7, 2025

Development

shutterstock_radiopharmafinal
Manufacturers face growing pressure to align drug design, production strategy, logistics, and workforce planning to ensure reliable, at-scale delivery.
Jan. 6, 2026
hikmagroundbreaking
Report finds 40 states and Puerto Rico are offering sales and tax exemptions to lower costs for new biomanufacturing and research and development facilities.
Dec. 4, 2025
PlantForm
2171_plantform_104_high_res
Advances in glycosylation control, plant engineering, and rapid-expression systems are redefining what’s possible for plant-made drugs and vaccines.
Nov. 13, 2025
fdawhiteoakbuilding
The agency is reviewing clinical trials that involve sending U.S. patients’ living cells to China and other “hostile countries” for genetic engineering and return infusion.
Sept. 22, 2025

Information Technology

resilience2
Software platforms can seamlessly integrate with emerging technologies to unlock efficiencies, strengthen sustainability and enable proactive prevention of disruptions.
Sept. 10, 2025
2_1200xundefined
Sponsored
Pharmaceutical manufacturing operates in a high-stakes environment where regulatory compliance, product integrity, and operational uptime are non-negotiable. As the industry becomes...
March 5, 2025
cdmo_trends_brief_image_1540x800
Sponsored
Discover the latest contract manufacturing key trends for the life science industry, including compliance, digital transformation and more. Don't let your organization fall behind...
Feb. 24, 2025
shutterstock_1401286556
To prioritize data integrity in the lab, companies must implement good data practices throughout the R&D process
June 24, 2024

Compliance

fda_shutterstock
While the FDA was hit with staffing and budget cuts this year, the agency managed to increase its inspection and enforcement activities.
Dec. 29, 2025
trump
In exchange for discounts to list prices on select medicines, the companies will receive relief from potential pharmaceutical tariffs over a three-year period.
Dec. 22, 2025
fdawhiteoakbuilding
The agency cited “significant violations” of current Good Manufacturing Practice regulations for finished pharmaceuticals at Novo Nordisk’s Bloomington facility.
Dec. 18, 2025
sun_pharmafinal
The pharmaceutical company is investing in a greenfield project as it looks to resolve ongoing FDA compliance issues at three existing Indian facilities.
Dec. 3, 2025

Quality & Risk

us_brit_trumpfinal
Atradius and GlobalData see Britain as having a competitive advantage in attracting pharmaceutical production, thanks to tariff exemptions for drug exports to U.S.
Jan. 26, 2026
shutterstock_2026final
Biomanufacturing scaling and supply chain resilience are top priorities for biopharma companies as they look to mitigate risks and capitalize on growth opportunities.
Jan. 5, 2026
shipcontainersheroimage
The industry requires local resilience and flexibility in a complex global landscape, according to separate reports from consulting firms Deloitte and West Monroe.
Dec. 11, 2025
aipicfinal
The adoption of artificial intelligence has evolved with investment shifting from monitoring to predictive intelligence, according to the 2025 LogiPharma AI Report.
Nov. 17, 2025